THE QUEENS MEDICAL CENTER has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, Hong Kong and EPO (European Patent Office). Its main competitors in its focus markets measurement, biotechnology and computer technology are QUEENS MEDICAL CT, GENIAL LIGHT CO LTD and AVL AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | Hong Kong | 4 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Organic fine chemistry | |
#5 | Audio-visual technology | |
#6 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Fleig Andrea | 11 |
#2 | Penner Reinhold | 11 |
#3 | Andrea Fleig | 3 |
#4 | Reinhold Penner | 3 |
#5 | Ernst Thomas Michael | 2 |
#6 | Prieto Thomas Edmund | 2 |
#7 | Armstrong Brian Stewart Randall | 2 |
#8 | Gallacher Thomas Scott | 1 |
#9 | Yu Jeffrey N N | 1 |
#10 | Lim John L | 1 |
Publication | Filing date | Title |
---|---|---|
AU2011254056A1 | Assays and methods for determining STIM2 activity | |
AU2011254061A1 | Functional identification of protein underlying ICRAC activity in a cell | |
AU2008230994A1 | Assays and methods for determining STIM2 activity | |
AU2007234630A1 | Methods of screening for LTRPC2 modulators | |
AU2007267546A1 | Methods of screening for TRPM4 modulators of insulin secretion | |
AU2890302A | Methods of screening for ltrpc2 modulators |